Ascend Wellness Holdings (AAWH) Total Debt Growth (3y) (2023 - 2026)
Ascend Wellness Holdings (AAWH) Total Debt Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | 15.43% |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | -7.08% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 11.33% |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | -3.67% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -10.43% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | -13.72% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | 92.83% |
| 10 | Ascend Wellness Holdings | 83.23 Mn | 16.23 Mn | 45.49 Mn | 5.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.10% |
| Mar 31, 2026 | -2.31% |
| Dec 31, 2025 | -0.07% |
| Sep 30, 2025 | 5.93% |
| Jun 30, 2025 | 6.03% |
| Mar 31, 2025 | 12.53% |
| Dec 31, 2024 | 13.73% |
| Sep 30, 2024 | 6.18% |
| Jun 30, 2024 | 33.92% |
| Mar 31, 2024 | 7.60% |
| Dec 31, 2023 | 13.04% |